Mafosfamide enhances interleukin-2-generated human effector cell cytotoxic activity against K562 myeloid leukaemia cells
作者： H. T. Hassan
DOI: 10.1007/BF02999862
关键词: Cytotoxicity 、 Cancer research 、 Cytokine 、 K562 cells 、 Mafosfamide 、 Leukemia 、 Cytotoxic T cell 、 Immunology 、 Interleukin 2 、 Biology 、 Cell culture
摘要:
springer.com
sci-hub.se 参考文章(9)
D Blaise, D Olive, AM Stoppa, P Viens, C Pourreau, M Lopez, M Attal, C Jasmin, G Monges, C Mawas, P Mannoni, P Palmer, C Franks, T Philip, D Maraninchi, Hematologic and immunologic effects of the systemic administration of recombinant interleukin-2 after autologous bone marrow transplantation Blood. ,vol. 76, pp. 1092- 1097 ,(1990) , 10.1182/BLOOD.V76.6.1092.1092
M. Sykes, M. L. Romick, D. H. Sachs, Interleukin 2 prevents graft-versus-host disease while preserving the graft-versus-leukemia effect of allogeneic T cells. Proceedings of the National Academy of Sciences of the United States of America. ,vol. 87, pp. 5633- 5637 ,(1990) , 10.1073/PNAS.87.15.5633
H. T. Hassan, A. Veit, H. R. Maurer, Synergistic interactions between differentiation-inducing agents in inhibiting the proliferation of HL-60 human myeloid leukaemia cells in clonogenic micro assays. Journal of Cancer Research and Clinical Oncology. ,vol. 117, pp. 227- 231 ,(1991) , 10.1007/BF01625429
Helen E. Heslop, Andrew S. Duncombe, Joyce E. Reittie, Concha Bello-Fernandez, David J. Gottlieb, H. Grant Prentice, Atul B. Mehta, A. Victor Hoffbrand, Malcolm K. Brenner, Interleukin 2 infusion induces haemopoietic growth factors and modifies marrow regeneration after chemotherapy or autologous marrow transplantation. British Journal of Haematology. ,vol. 77, pp. 237- 244 ,(1991) , 10.1111/J.1365-2141.1991.TB07983.X
H. Rainer Maurer, Hassan Tawhid Hassan, Agar Capillary Clonogenic Microassays for Cellular Immunocytotoxic Activities in Human Leukaemia and Lymphoma Leukemia & Lymphoma. ,vol. 9, pp. 305- 313 ,(1993) , 10.3109/10428199309148527
H. T. Hassan, J. K. H. Rees, Triple combination of retinoic acid + low concentration of cytosine arabinoside + hexamethylene bisacetamide induces differentiation of human aml blasts in primary culture Hematological Oncology. ,vol. 7, pp. 429- 440 ,(1989) , 10.1002/HON.2900070606
Tomasz Skórski, Maciej Kawalec, Jerzy Kawiak, Successful adoptive immunotherapy of minimal residual disease after chemoradiotherapy and transplantation of bone marrow purged of leukaemia with mafosfamide. Cancer Immunology, Immunotherapy. ,vol. 32, pp. 71- 74 ,(1990) , 10.1007/BF01741728
M S Mitchell, R A Kempf, W Harel, H Shau, W D Boswell, S Lind, E C Bradley, Effectiveness and tolerability of low-dose cyclophosphamide and low-dose intravenous interleukin-2 in disseminated melanoma [corrected]. Journal of Clinical Oncology. ,vol. 6, pp. 409- 424 ,(1988) , 10.1200/JCO.1988.6.3.409
L. Mangoni, A. M. Carella, C. Carlo-Stella, V. Rizzolli, Autologous marrow transplantation in acute lymphoblastic leukemia: Control of residual disease with mafosfamide and induction of syngeneic GVHD with cyclosporin Bone Marrow Transplantation. ,vol. 6, pp. 76- 78 ,(1990)